VirnetX CEO sells 20,425 shares under plan

Q: What insider transactions did VHC’s CEO Kendall Larsen report in this Form 4?

Kendall Larsen reported three open-market sales of VirnetX common stock on September 10, 11, and 14, 2026, totaling 20,425 shares. All transactions involved common stock held directly.

Q: How many VirnetX (VHC) shares did Kendall Larsen sell and at what prices?

The filing reports sales of 8,000 shares at $11.483 on September 10, 8,000 shares at $11.373 on September 11, and 4,425 shares at $11.174 on September 14, 2026. Each reported price is a weighted average over ranges disclosed in footnotes.

Q: What indirect VirnetX (VHC) holdings associated with Kendall Larsen are disclosed?

As of September 10, 2026, the filing lists 74,649 shares held indirectly by the reporting person’s spouse, 30,676 shares held by The Kathleen Sheehan Revocable Trust, and 15,000 shares held by The K2 Investment Fund LLC.

Q: Does the Form 4 show Kendall Larsen’s total direct VirnetX (VHC) holdings after these sales?

No. For these sale transactions, the post-transaction direct share balance is not stated. Only the number of shares sold and certain indirect ownership balances are disclosed.

Q: How are the VirnetX (VHC) sale price ranges described in the Form 4 footnotes?

Each per-share sale price is a weighted average. The September 10 sale ranged from $11.06 to $11.99, the September 11 sale from $11.16 to $11.62, and the September 14 sale from $10.71 to $11.60, with full breakdowns available on request.

VirnetX’s CEO and major shareholder reported three Rule 10b5-1 planned open-market sales totaling 20,425 shares of common stock and disclosed several indirect ownership positions.

Available on EDGAR 09/14/2026 - 08:26 PM EDT Accepted by SEC EDGAR 09/14/2026 - 08:26 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

VirnetX Holding Corp (VHC) reported that President & CEO and ten percent owner Kendall Larsen sold a total of 20,425 shares of common stock in open‑market transactions on September 10, 11, and 14, 2026, under a Rule 10b5-1 trading plan adopted on May 29, 2026. The filing also lists indirect holdings of common stock held by the reporting person’s spouse, a revocable trust, and an investment fund.

Insider Trade Summary 10b5-1

Net Seller: 20,425 shares

Net Sell 3 txns

Insider Larsen Kendall

Role President & CEO

Sold 20,425 shs ($232K)

Share of Position Sold 5.7%

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F4}	4,425	$11.174	$49K
Sale	Common Stock ^{F1, F3}	8,000	$11.373	$91K
Sale	Common Stock ^{F1, F2}	8,000	$11.483	$92K
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 339,633 shares (Direct); Common Stock — 74,649 shares (Indirect, By: Spouse); Common Stock — 30,676 shares (Indirect, By: The Kathleen Sheehan Revocable Trust dtd 2/5/2009); Common Stock — 15,000 shares (Indirect, By: The K2 Investment Fund LLC)

Holdings Before and After: Common Stock, 360,058 to 339,633 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (4)

F1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026.
F2. This sale price represents the weighted average sale price of the shares sold ranging from $11.06 to $11.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3. This sale price represents the weighted average sale price of the shares sold ranging from $11.16 to $11.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4. This sale price represents the weighted average sale price of the shares sold ranging from $10.71 to $11.60 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Key Figures

Shares sold September 10, 2026: 8,000 shares at $11.483 per share Shares sold September 11, 2026: 8,000 shares at $11.373 per share Shares sold September 14, 2026: 4,425 shares at $11.174 per share +4 more

7 metrics

Shares sold September 10, 2026 8,000 shares at $11.483 per share Open-market sale of VirnetX common stock by Kendall Larsen

Shares sold September 11, 2026 8,000 shares at $11.373 per share Open-market sale of VirnetX common stock by Kendall Larsen

Shares sold September 14, 2026 4,425 shares at $11.174 per share Open-market sale of VirnetX common stock by Kendall Larsen

Total shares sold 20,425 shares Net shares sold across the three reported transactions

Indirect holding by spouse 74,649 shares Indirect ownership of VirnetX common stock as of September 10, 2026

Indirect holding by revocable trust 30,676 shares Held by The Kathleen Sheehan Revocable Trust dtd 2/5/2009

Indirect holding by K2 Investment Fund LLC 15,000 shares Held by The K2 Investment Fund LLC as of September 10, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, indirect ownership

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"This sale price represents the weighted average sale price of the shares sold"

indirect ownership financial

"Common Stock, indirect ownership by spouse, trust, and investment fund"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did VHC’s CEO Kendall Larsen report in this Form 4?

Kendall Larsen reported three open-market sales of VirnetX common stock on September 10, 11, and 14, 2026, totaling 20,425 shares. All transactions involved common stock held directly.

How many VirnetX (VHC) shares did Kendall Larsen sell and at what prices?

The filing reports sales of 8,000 shares at $11.483 on September 10, 8,000 shares at $11.373 on September 11, and 4,425 shares at $11.174 on September 14, 2026. Each reported price is a weighted average over ranges disclosed in footnotes.

Were Kendall Larsen’s VirnetX (VHC) stock sales under a Rule 10b5-1 plan?

Yes. A footnote states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026, and the plan-status checkbox is affirmed, indicating the trades followed a pre-arranged plan.

What indirect VirnetX (VHC) holdings associated with Kendall Larsen are disclosed?

As of September 10, 2026, the filing lists 74,649 shares held indirectly by the reporting person’s spouse, 30,676 shares held by The Kathleen Sheehan Revocable Trust, and 15,000 shares held by The K2 Investment Fund LLC.

Does the Form 4 show Kendall Larsen’s total direct VirnetX (VHC) holdings after these sales?

No. For these sale transactions, the post-transaction direct share balance is not stated. Only the number of shares sold and certain indirect ownership balances are disclosed.

How are the VirnetX (VHC) sale price ranges described in the Form 4 footnotes?

Each per-share sale price is a weighted average. The September 10 sale ranged from $11.06 to $11.99, the September 11 sale from $11.16 to $11.62, and the September 14 sale from $10.71 to $11.60, with full breakdowns available on request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larsen Kendall

(Last)

(First)

(Middle)

C/O 308 DORLA COURT

(Street)

ZEPHYR COVE

NEVADA

89448

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VirnetX Holding Corp [ VHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/10/2026		S⁽¹⁾		8,000	D	$11.483⁽²⁾	352,058	D
Common Stock	09/11/2026		S⁽¹⁾		8,000	D	$11.373⁽³⁾	344,058	D
Common Stock	09/14/2026		S⁽¹⁾		4,425	D	$11.174⁽⁴⁾	339,633	D
Common Stock								74,649	I	By: Spouse
Common Stock								30,676	I	By: The Kathleen Sheehan Revocable Trust dtd 2/5/2009
Common Stock								15,000	I	By: The K2 Investment Fund LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026.

2. This sale price represents the weighted average sale price of the shares sold ranging from $11.06 to $11.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

3. This sale price represents the weighted average sale price of the shares sold ranging from $11.16 to $11.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

4. This sale price represents the weighted average sale price of the shares sold ranging from $10.71 to $11.60 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	/s/ Kendall Larsen	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR